Article
Improving the efficiency of liver targeting rAAV-mediated homologous recombination using ribonucleotide reductase inhibitors
2020-12-10
Abstract excerpt
<title>Abstract</title> <p>Recombinant adeno-associated viral (rAAV) vectors continue to gain popularity for <italic>in vivo</italic> therapeutic gene delivery. Homologous recombination-based gene therapy using rAAV (AAV-HR) without nucleases has several advantages over classical gene therapy, especially when targeting the liver in neonatal/pediatric populations due to its potential for permanent sustained transg...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b120fcd0-849b-5c17-94e2-0d94409ad71b
- DOI
- 10.21203/rs.3.rs-106148/v1
